CT
ASTH icon

Clearstead Trust’s Astrana Health ASTH Stock Holding History

Clearstead Trust’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14
Closed -$397 – 1569
2025
Q3 		$397 Hold
14
– – ﹤0.01% 1412
2025
Q2 		$349 Buy
+14
New +$394 ﹤0.01% 1397

Other funds holding ASTH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
3C
325 Capital New York $419M AUM 75.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SW
SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Clearstead Trust's ASTH Position: Q4 2025 in Review

Clearstead Trust sold out of Astrana Health (ASTH) in Q4 2025, closing a stake of 14 shares — an estimated $397 sold.

Clearstead Trust first reported a position in ASTH in Q2 2025 and held it in 2 quarters. The position peaked at $397 in Q3 2025. 175 funds tracked by Wall St. Rank hold ASTH as of Q4 2025.

  • Clearstead Trust reported no remaining Astrana Health position as of Q4 2025 after selling out during the quarter.
  • Clearstead Trust sold 14 Astrana Health shares in Q4 2025, an estimated $397.
  • Clearstead Trust first reported a position in Astrana Health in Q2 2025 and held it in 2 quarters.
  • Clearstead Trust's Astrana Health position peaked at $397 in Q3 2025.
  • 175 funds tracked by Wall St. Rank held Astrana Health as of Q4 2025.

Based on Clearstead Trust's 13F filing for Q4 2025, filed 9 Feb 2026.